Maryland

Businessman about to be crushed by falling dominos

BioNTech to wind down cell therapy manufacturing in Maryland

After a poor performance from its CAR-T candidate in a phase 1 cancer trial, BioNTech is ending cell therapy manufacturing at its first U.S. plant.

Fraiser Kansteiner Jun 18, 2025 10:23am

AZ tacks on $2B to its investment in US manufacturing, R&D

Nov 12, 2024 10:10am

AZ brings its cell therapy ambitions to MD with $300M investment

Feb 6, 2024 10:05am

Gilead Kite manufacturing facility

Gilead assembles CAR-T manufacturing troika with new FDA nod

Apr 19, 2022 10:45am

FDA Building 2

FDA scolds Jubilant in the first public Form 483 in months

Aug 23, 2021 11:15am

Ugur Sahin

BioNTech is taking over a Kite Pharma cell therapy plant in MD

Jul 19, 2021 11:01am